Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
AR protein | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 1 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
TDP1 protein | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
progesterone receptor | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
caspase-3 | 2 | 0 | 0 | 2 |
RAD51 | 0 | 1 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Interferon beta | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
Pantothenate synthetase | 0 | 1 | 0 | 1 |
Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 3 | 0 | 0 | 3 |
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
D(2) dopamine receptor | 0 | 6 | 0 | 6 |
Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 1B | 0 | 6 | 0 | 6 |
D(3) dopamine receptor | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
5-hydroxytryptamine receptor 6 | 0 | 6 | 0 | 6 |
endonuclease IV | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
arylsulfatase A | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 4 | 2 | 8 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
Androgen receptor | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 3 | 2 | 6 |
Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
GLS protein | 1 | 0 | 0 | 1 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 2 | 2 | 4 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Chain A, CES1 protein | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
PPM1D protein | 2 | 0 | 0 | 2 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 1 | 3 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 2 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |